VTGN   $0.3684  46.54% Market Closed After Close 0.3449 -6.38%

Vistagen Therapeutics, Inc.

EMA (20): The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

EMA (50): 2026-06-30 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2025-12-17 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

Trend Type down and flat
Power medium strength
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 0.0
EMA (20) date of signal Sept. 22, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield 11.24%
EMA (50) date of signal June 30, 2026, 3 a.m.
EMA (100) Signals None
EMA (100) Yield 0.0
EMA (100) date of signal
RSI Signals bullish
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 22, 2026, 3 a.m.
MACD Signals bearish weakening
MACD Yield 7.62%
MACD date of signal Sept. 17, 2026, 3 a.m.
Stochastic Signals bearish weakening
Stochastic Yield 4.75%
Stochastic date of signal Sept. 18, 2026, 3 a.m.
Updated Sept. 23, 2026, 11:03 p.m.